Santhera Pharmaceuticals Holding AG (LON: 0QN1)
London
· Delayed Price · Currency is GBP · Price in CHF
16.39
+1.23 (8.13%)
At close: Jan 22, 2025
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 45 employees as of December 30, 2023. The number of employees decreased by 1 or -2.18% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.18%
Revenue / Employee
2.22M GBP
Profits / Employee
1.23M GBP
Market Cap
186.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Santhera Pharmaceuticals Holding AG News
- 7 days ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 17 days ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 6 weeks ago - Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy - Benzinga
- 4 months ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire